发明名称 |
COMBINATION OF TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR (TACI) AND ANTI-CD20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE (TACI)-CD20 |
摘要 |
A therapeutically effective amount of an extracellular domain of a transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) polypeptide comprising a secreted form of SEQ ID NO:23 and an anti-CD-20 agent comprising rituximab, for use in reducing B cell numbers in a mammal, wherein said therapeutically effective amount results in a synergistic reduction in the number of memory B cells. |
申请公布号 |
HK1148948(A1) |
申请公布日期 |
2017.02.24 |
申请号 |
HK20110103143 |
申请日期 |
2011.03.29 |
申请人 |
ZymoGenetics Inc. |
发明人 |
Broly, Herve;Ponce Jr., Rafael A.;Graffner, Hans Otto Lennart;Peano, Sergio |
分类号 |
A61K;A61P;C07K |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|